Mirum Pharmaceuticals Overview
Mirum Pharmaceuticals Target Price
Analysts' 12-month price predictions for MIRM.
Share Price
$76.06
Average Target Price
$85.00
11.8% upside
11.8% upside2 analysts in the last 4 months
High: $89 | Low: $81
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-08-11 | Stifel NicolausJames Condulis | $89 | 17% upside |  |
| 2025-08-07 | JMP SecuritiesJonathan Wolleben | $81 | 6.5% upside | |
| 2024-11-12 | Stifel NicolausDae Gon Ha | $70 |  8% downside | |
| 2024-08-08 | Robert W. BairdBrian Skorney | $44 | 42.2% downside | |
| 2024-06-17 | Evercore ISIGavin Clark-Gartner | $62 | 18.5% downside | |
| 2024-06-17 | Morgan StanleyMichael E Ulz | $57 | 25.1% downside | |
| 2024-06-17 | H.C. WainwrightEd Arce | $66 | 13.2% downside | |
| 2024-06-17 | Robert W. BairdBrian Skorney | $39 | 48.7% downside | |
| 2024-05-23 | Cantor FitzgeraldJoshua Schimmer | $45 | 40.8% downside | |
| 2024-04-16 | Stifel NicolausDae Gon Ha | $48 | 36.9% downside | |
| 2024-03-14 | H.C. WainwrightEd Arce | $58 | 23.7% downside | |
| 2023-01-10 | Leerink Partners | $39 | 48.7% downside | |
| 2022-12-14 | Leerink Partners | $50 | 34.3% downside | |
| 2022-05-23 | H.C. Wainwright | $69 | 9.3% downside | |
| 2022-05-06 | Raymond James | $75 | 1.4% downside | |
| 2022-04-26 | Leerink Partners | $49 | 35.6% downside | |